Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03056157 · ClinicalTrials.gov registry record · NA
Psychosocial Rehabilitation After Moral Injury and Loss With Adaptive Disclosure
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 174
- Enrollment target
NCT03056157: Completed NA study, sponsored by VA Office of Research and Development.
NCT03056157 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 174 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03056157, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
Study Summary
The aim of this study was to determine the efficacy of Adaptive Disclosure for Moral Injury and Loss (AD-MIL), a combat-specific psychotherapy for war-related PTSD stemming from Moral Injury (MI) and traumatic loss (TL) with Iraq and Afghanistan War Veterans with PTSD. AD-MIL will be compared to Present Centered Therapy (PCT). AD-MIL is a modified version of Adaptive Disclosure (AD), which has been modified and extended to solely treat MI and TL by targeting psychological and behavioral obstacles to occupational, relationship, and family functioning, as well as quality of life. PCT is a manualized evidenced-based PTSD treatment used to address functioning problems in several large-scale PTSD trials. The primary end-point was psychosocial functioning (improvements in social, educational and occupational functions). Secondary end-points included PTSD, depression, moral emotions (anger, shame, and guilt), alcohol use, self-compassion, and mindful/valued living.
Interventions
- BEHAVIORAL Present Centered Therapy
- BEHAVIORAL Adaptive Disclosure for Moral Injury and Loss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2018-01-03 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03056157
The ClinicalTrials.gov registry entry for NCT03056157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Present Centered Therapy is the first listed.
NCT03056157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03056157 about?
NCT03056157 is a clinical study titled "Psychosocial Rehabilitation After Moral Injury and Loss With Adaptive Disclosure". The aim of this study was to determine the efficacy of Adaptive Disclosure for Moral Injury and Loss (AD-MIL), a combat-specific psychotherapy for war-related PTSD stemming from Moral Injury (MI) and traumatic loss (TL) with Iraq and Afghanistan War Veterans with PTSD. AD-MIL will be compared to Pre...
What is the current status of trial NCT03056157?
This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2018-01-03. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT03056157?
The interventions under investigation include: Present Centered Therapy (BEHAVIORAL), Adaptive Disclosure for Moral Injury and Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT03056157?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.